Clinical research of Gegensu injection combined with levodopa on parkinson's disease
10.3969/j.issn.1005-1678.2017.09.034
- VernacularTitle:葛根素注射液联合左旋多巴治疗帕金森病的临床研究
- Author:
Haixia WANG
;
Xinhua FANG
;
Xinyu WANG
- Keywords:
Gegensu injection;
levodopa;
parkinson's disease
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(9):86-88
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical efficacy of puerarin injection combined with levodopa in the treatment of Parkinson. Methods 126 Parkinson patients were grouped into two groups randomly. Control group was treated with levodopa and observation group was added to Gegensu injection. Results 3 months later, UPDRS scale score, ADL and HAMD score of observation group were lower than that of control group(P<0.05).Serum Hcy and plasma hs-CRP level of observation group were lower than that of control group( P<0.05).Adverse reactions of observation group was 6.35％ during treatment, compared with the control group 9.52％ had no significant difference. Conclusion Gegensu injection can help improve cognitive ability and improve self-care ability in patients with Parkinson, alleviate symptoms and medication safety.
